Cellosaurus GLC-4/ADRpr (CVCL_A5AZ)
Cell line name | GLC-4/ADRpr |
---|---|
Synonyms | GLC4/ADRpr; GLC4-Adr2 |
Accession | CVCL_A5AZ |
Resource Identification Initiative | To cite this cell line use: GLC-4/ADRpr (RRID:CVCL_A5AZ) |
Comments | Characteristics: Partial revertant of GLC-4/ADR obtained after culturing in drug-free medium for a number of months (3 according to PubMed=3040227 and 6 according to PubMed=7809167). Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
Sequence variations |
|
Disease | Lung small cell carcinoma (NCIt: C4917) Small cell lung cancer (ORDO: Orphanet_70573) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_4997 (GLC-4/ADR) |
Sex of cell | Male |
Age at sampling | Age unspecified |
Category | Cancer cell line |
Publications | PubMed=3040227 PubMed=7809167; DOI=10.1073/pnas.91.26.13033; PMCID=PMC45575 |
Cross-references | |
Encyclopedic resources | Wikidata; Q107115108 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 19-Dec-2024 |
Version number | 6 |